Advertisement

Comment on “Clinical features and three-year prognosis of AECOPD patients with different levels of blood eosinophils”

Published:November 11, 2022DOI:https://doi.org/10.1016/j.hrtlng.2022.10.018
      To the Editor,

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart & Lung: The Journal of Cardiopulmonary and Acute Care
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ruiying W
        • Zhaoyun Jianying X
        Clinical features and three-year prognosis of AECOPD patients with different levels of blood eosinophils.
        Heart Lung. 2022; 56 (Nov-DecEpub 2022 Jun 7PMID35687923): 29-39https://doi.org/10.1016/j.hrtlng.2022.05.012
        • Hastie AT
        • Martinez FJ
        • Curtis JL
        • Doerschuk CM
        • Hansel NN
        • Christenson S
        • Putcha N
        • Ortega VE
        • Li X
        • Barr RG
        • Carretta EE
        • Couper DJ
        • Cooper CB
        • Hoffman EA
        • Kanner RE
        • Kleerup E
        • O'Neal WK
        • Paine 3rd, R
        • Peters SP
        • Alexis NE
        • Woodruff PG
        • Han MK
        • Meyers DA
        • Bleecker ER
        SPIROMICS investigators. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
        Lancet Respir Med. 2017; 5 (2017 DecEpubNov 13PMID29146301PMCIDPMC5849066): 956-967https://doi.org/10.1016/S2213-2600(17)30432-0
        • DiSantostefano RL
        • Hinds D
        • Le HV
        • Barnes NC.
        Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort.
        Respir Med. 2016; 112 (MarEpub 2016 Jan 22PMID26872700): 88-96https://doi.org/10.1016/j.rmed.2016.01.013
        • You Y
        • Shi GC.
        Blood Eosinophils and Clinical Outcome of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
        Respiration. 2021; 100 (Epub 2020 Dec 29PMID33373986): 228-237https://doi.org/10.1159/000510516
        • Pascoe S
        • Barnes N
        • Brusselle G
        • Compton C
        • Criner GJ
        • Dransfield MT
        • Halpin DMG
        • Han MK
        • Hartley B
        • Lange P
        • Lettis S
        • Lipson DA
        • Lomas DA
        • Martinez FJ
        • Papi A
        • Roche N
        • van der Valk RJP
        • Wise R
        • Singh D.
        Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
        Lancet Respir Med. 2019; 7 (SepEpub 2019 Jul 4Erratum inLancet Respir Med. 2021 Dec912e114PMID31281061): 745-756https://doi.org/10.1016/S2213-2600(19)30190-0